ACS Infectious Diseases, volume 9, issue 3, pages 394-422

From Antibacterial to Antibiofilm Targeting: An Emerging Paradigm Shift in the Development of Quaternary Ammonium Compounds (QACs)

Publication typeJournal Article
Publication date2023-02-15
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor5.3
ISSN23738227
Infectious Diseases
Abstract
In a previous development stage, mostly individual antibacterial activity was a target in the optimization of biologically active compounds and antiseptic agents. Although this targeting is still valuable, a new trend has appeared since the discovery of superhigh resistance of bacterial cells upon their aggregation into groups. Indeed, it is now well established that the great majority of pathogenic germs are found in the environment as surface-associated microbial communities called biofilms. The protective properties of biofilms and microbial resistance, even to high concentrations of biocides, cause many chronic infections in medical settings and lead to serious economic losses in various areas. A paradigm shift from individual bacterial targeting to also affecting more complex cellular frameworks is taking place and involves multiple strategies for combating biofilms with compounds that are effective at different stages of microbiome formation. Quaternary ammonium compounds (QACs) play a key role in many of these treatments and prophylactic techniques on the basis of both the use of individual antibacterial agents and combination technologies. In this review, we summarize the literature data on the effectiveness of using commercially available and newly synthesized QACs, as well as synergistic treatment techniques based on them. As an important focus, techniques for developing and applying antimicrobial coatings that prevent the formation of biofilms on various surfaces over time are discussed. The information analyzed in this review will be useful to researchers and engineers working in many fields, including the development of a new generation of applied materials; understanding biofilm surface growth; and conducting research in medical, pharmaceutical, and materials sciences. Although regular studies of antibacterial activity are still widely conducted, a promising new trend is also to evaluate antibiofilm activity in a comprehensive study in order to meet the current requirements for the development of highly needed practical applications.

Citations by journals

1
2
ACS Infectious Diseases
ACS Infectious Diseases, 2, 7.14%
ACS Infectious Diseases
2 publications, 7.14%
Chemistry of Heterocyclic Compounds
Chemistry of Heterocyclic Compounds, 2, 7.14%
Chemistry of Heterocyclic Compounds
2 publications, 7.14%
International Journal of Molecular Sciences
International Journal of Molecular Sciences, 1, 3.57%
International Journal of Molecular Sciences
1 publication, 3.57%
Frontiers in Bioengineering and Biotechnology
Frontiers in Bioengineering and Biotechnology, 1, 3.57%
Frontiers in Bioengineering and Biotechnology
1 publication, 3.57%
Molecules
Molecules, 1, 3.57%
Molecules
1 publication, 3.57%
Progress in Organic Coatings
Progress in Organic Coatings, 1, 3.57%
Progress in Organic Coatings
1 publication, 3.57%
Journal of Supercritical Fluids
Journal of Supercritical Fluids, 1, 3.57%
Journal of Supercritical Fluids
1 publication, 3.57%
ACS applied materials & interfaces
ACS applied materials & interfaces, 1, 3.57%
ACS applied materials & interfaces
1 publication, 3.57%
Tetrahedron
Tetrahedron, 1, 3.57%
Tetrahedron
1 publication, 3.57%
Polymers
Polymers, 1, 3.57%
Polymers
1 publication, 3.57%
Heliyon
Heliyon, 1, 3.57%
Heliyon
1 publication, 3.57%
Mendeleev Communications
Mendeleev Communications, 1, 3.57%
Mendeleev Communications
1 publication, 3.57%
Pharmaceutics
Pharmaceutics, 1, 3.57%
Pharmaceutics
1 publication, 3.57%
Nanomaterials
Nanomaterials, 1, 3.57%
Nanomaterials
1 publication, 3.57%
Building and Environment
Building and Environment, 1, 3.57%
Building and Environment
1 publication, 3.57%
Angewandte Chemie
Angewandte Chemie, 1, 3.57%
Angewandte Chemie
1 publication, 3.57%
Angewandte Chemie - International Edition
Angewandte Chemie - International Edition, 1, 3.57%
Angewandte Chemie - International Edition
1 publication, 3.57%
Chemical Engineering Journal
Chemical Engineering Journal, 1, 3.57%
Chemical Engineering Journal
1 publication, 3.57%
Frontiers in Cellular and Infection Microbiology
Frontiers in Cellular and Infection Microbiology, 1, 3.57%
Frontiers in Cellular and Infection Microbiology
1 publication, 3.57%
IET Nanobiotechnology
IET Nanobiotechnology, 1, 3.57%
IET Nanobiotechnology
1 publication, 3.57%
Russian Journal of General Chemistry
Russian Journal of General Chemistry, 1, 3.57%
Russian Journal of General Chemistry
1 publication, 3.57%
Starch/Staerke
Starch/Staerke, 1, 3.57%
Starch/Staerke
1 publication, 3.57%
Advanced healthcare materials
Advanced healthcare materials, 1, 3.57%
Advanced healthcare materials
1 publication, 3.57%
ChemMedChem
ChemMedChem, 1, 3.57%
ChemMedChem
1 publication, 3.57%
Russian Journal of Inorganic Chemistry
Russian Journal of Inorganic Chemistry, 1, 3.57%
Russian Journal of Inorganic Chemistry
1 publication, 3.57%
1
2

Citations by publishers

1
2
3
4
5
6
7
Elsevier
Elsevier, 7, 25%
Elsevier
7 publications, 25%
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 5, 17.86%
Multidisciplinary Digital Publishing Institute (MDPI)
5 publications, 17.86%
Wiley
Wiley, 5, 17.86%
Wiley
5 publications, 17.86%
American Chemical Society (ACS)
American Chemical Society (ACS), 3, 10.71%
American Chemical Society (ACS)
3 publications, 10.71%
Frontiers Media S.A.
Frontiers Media S.A., 2, 7.14%
Frontiers Media S.A.
2 publications, 7.14%
Springer Nature
Springer Nature, 2, 7.14%
Springer Nature
2 publications, 7.14%
Pleiades Publishing
Pleiades Publishing, 2, 7.14%
Pleiades Publishing
2 publications, 7.14%
Institution of Engineering and Technology (IET)
Institution of Engineering and Technology (IET), 1, 3.57%
Institution of Engineering and Technology (IET)
1 publication, 3.57%
1
2
3
4
5
6
7
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Saverina E. A. et al. From Antibacterial to Antibiofilm Targeting: An Emerging Paradigm Shift in the Development of Quaternary Ammonium Compounds (QACs) // ACS Infectious Diseases. 2023. Vol. 9. No. 3. pp. 394-422.
GOST all authors (up to 50) Copy
Saverina E. A., Frolov N. A., Kamanina O. A., Arlyapov V. A., Vereshchagin A. N., Ananikov V. P. From Antibacterial to Antibiofilm Targeting: An Emerging Paradigm Shift in the Development of Quaternary Ammonium Compounds (QACs) // ACS Infectious Diseases. 2023. Vol. 9. No. 3. pp. 394-422.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1021/acsinfecdis.2c00469
UR - https://doi.org/10.1021%2Facsinfecdis.2c00469
TI - From Antibacterial to Antibiofilm Targeting: An Emerging Paradigm Shift in the Development of Quaternary Ammonium Compounds (QACs)
T2 - ACS Infectious Diseases
AU - Saverina, Evgeniya A.
AU - Frolov, Nikita A.
AU - Kamanina, Olga A.
AU - Arlyapov, Vyacheslav A.
AU - Vereshchagin, Anatoly N.
AU - Ananikov, Valentine P.
PY - 2023
DA - 2023/02/15 00:00:00
PB - American Chemical Society (ACS)
SP - 394-422
IS - 3
VL - 9
SN - 2373-8227
ER -
BibTex |
Cite this
BibTex Copy
@article{2023_Saverina,
author = {Evgeniya A. Saverina and Nikita A. Frolov and Olga A. Kamanina and Vyacheslav A. Arlyapov and Anatoly N. Vereshchagin and Valentine P. Ananikov},
title = {From Antibacterial to Antibiofilm Targeting: An Emerging Paradigm Shift in the Development of Quaternary Ammonium Compounds (QACs)},
journal = {ACS Infectious Diseases},
year = {2023},
volume = {9},
publisher = {American Chemical Society (ACS)},
month = {feb},
url = {https://doi.org/10.1021%2Facsinfecdis.2c00469},
number = {3},
pages = {394--422},
doi = {10.1021/acsinfecdis.2c00469}
}
MLA
Cite this
MLA Copy
Saverina, Evgeniya A., et al. “From Antibacterial to Antibiofilm Targeting: An Emerging Paradigm Shift in the Development of Quaternary Ammonium Compounds (QACs).” ACS Infectious Diseases, vol. 9, no. 3, Feb. 2023, pp. 394-422. https://doi.org/10.1021%2Facsinfecdis.2c00469.
Found error?